Do Surgical Site Infections in Open Aortoiliac Surgery Differ Between Occlusive and Aneurysmal Arterial Disease?

Abstract

Background:

Surgical site infections (SSI) are frequently seen after aortoiliac vascular surgery (2%-14%). Deep SSIs are associated with graft infection, sepsis, and mortality. This study evaluates the difference in incidence and nature of SSI following open aortoiliac surgery for aneurysmal disease compared to occlusive arterial disease.

Methods:

A retrospective cohort study was conducted, including all consecutive patients who underwent open aortoiliac vascular surgery between January 2005 and December 2016 in the Amphia Hospital, Breda, the Netherlands. Patients were grouped by disease type, either aneurysmal or occlusive arterial disease. Data were gathered, including patient characteristics, potential risk factors, and development of SSI. Surgical site infections were defined in accordance with the criteria of the Centers for Disease Control.

Results:

Between January 2005 and December 2016, a total of 756 patients underwent open aortoiliac surgery of which 517 had aortoiliac aneurysms and 225 had aortoiliac occlusive disease. The group with occlusive disease was younger, predominantly male, and had more smokers. After exclusion of 228 patients undergoing acute surgery, the SSI rate after elective surgery was 6.2%, with 10 of 301 SSIs in the aneurysmal group (3.0%) and 22 of 213 SSIs in the group with occlusive disease (10.3%, P < .001). Also, infection-related readmission and reintervention were higher after occlusive surgery, 6.6% versus 0.9% (P < .001) and 4.2% versus 0.9% (P = .003), respectively. Staphylococcus aureus was found as the most common pathogen, causing 64% of SSI in occlusive disease versus 10% in aneurysmal disease (P = .005). Logistic regression showed occlusive arterial disease and chronic renal disease were associated with SSI.

Conclusion:

Our study presents evidence for a higher rate of SSI in patients with aortoiliac occlusive disease compared to aortoiliac aneurysmal disease, in part due to inherent use of inguinal incision in patients with occlusive disease. All precautions to prevent SSI should be taken in patients undergoing vascular surgery for arterial occlusive disease.

Keywords

surgical site infection vascular surgery aortoiliac aneurysm aortic aneurysm aortoiliac occlusive disease

Get full access to this article

View all access options for this article.

References

Faizer

Dombrovskiy

Vogel

. Impact of hospital-acquired infection on long-term outcomes after endovascular and open abdominal aortic aneurysm repair. Ann Vasc Surg. 2014;28(4):823–830. doi:10.1016/j.avsg.2013.06.028

Inui

Bandyk

. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2015;28(3-4):201–207. doi:10.1053/j.semvascsurg.2016.02.002

Giles

Wyers

Pomposelli

Hamdan

Avery Ching

Schermerhorn

. The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-2007. J Vasc Surg. 2010;52(6):1471–1477. doi:10.1016/j.jvs.2010.07.013

De Rango

Cao

. Long-term results of OVER: the dream of EVAR is not over. Eur J Vasc Endovasc Surg. 2013;45(4):313–314. doi:10.1016/j.ejvs.2013.01.013

Prinssen

Buskens

Blankensteijn

. The Dutch Randomised Endovascular Aneurysm Management (DREAM) trial. Background, design and methods. J Cardiovasc Surg (Torino). 2002;43(3):379–384.

Ghammad

Dupuis

Amond

, et al. Total laparoscopic bypass is safe and effective for aortoiliac occlusive disease. J Vasc Surg. 2015;61(3):698–702. doi:10.1016/j.jvs.2014.10.018

Pejkić

Dragaš

Ilić

, et al. Incidence and relevance of groin incisional complications after aortobifemoral bypass grafting. Ann Vasc Surg. 2014;28(8):1832–1839. doi:10.1016/j.avsg.2014.06.064

Sen

Stephen

Agarwal

. Clinical profile of aortoiliac occlusive disease and outcomes of aortobifemoral bypass in India. J Vascu Surg. 2013;57(2 Suppl):20S–5S. doi:10.1016/j.jvs.2012.06.113

Mussa

Hedayati

Zhou

, et al. Prevention and treatment of aortic graft infection. Expert Rev Anti Infect Ther. 2007;5(2):305–315. doi:10.1586/14787210.5.2.305

10.

Young

Cherry

Davis

, et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg. 1999;178(2):136–140. doi:10.1016/S0002-9610(99)00146-4

11.

Dirven

Van Der Jagt

Barendregt

Van Der Vliet

. The efficacy of autologous femoropopliteal vein reconstruction for primary aortic and aortic graft infection. Ann Vasc Surg. 2015;29(6):1188–1195. doi:10.1016/j.avsg.2015.03.043

12.

Langenberg

JCM

Kluytmans

JAJW

De Groot

HGW

, et al. Wound and graft infections in endovascular and open abdominal aortic aneurysm surgery. Surg Infect (Larchmt). 2018;19(4):424–429.

13.

Rossi

Carpi

. Skin microcirculation in peripheral arterial obliterative disease. Biomed Pharmacother. 2004;58(8):427–431. doi:10.1016/j.biopha.2004.08.004

14.

Kabbani

Rotter

Busche

, et al. Impact of diabetes and peripheral arterial occlusive disease on the functional microcirculation at the plantar foot. Plast Reconstr Surg Glob Open. 2013;1(7):e48. doi:10.1097/GOX.0b013e3182a4b9cb

15.

Abularrage

Sidawy

Aidinian

Singh

Weiswasser

Arora

. Evaluation of the microcirculation in vascular disease. J Vasc Surg. 2005;42(3):574–581. doi:10.1016/j.jvs.2005.05.019

16.

Horan

Andrus

Dudeck

. CDC/NHSN surveillance definitions for specific types of infections. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.002

17.

Szilagyi

Smith

Elliott

Vrandecic

. Infection in arterial reconstruction with synthetic grafts. Ann Surg. 1972;176(3):321–333. doi:10.1097/00000658-197209000-00008

18.

van der Slegt

van der Laan

Veen

Hendriks

Romme

Kluytmans

. Implementation of a bundle of care to reduce surgical site infections in patients undergoing vascular surgery. PLoS One. 2013;8(8):e71566. doi:10.1371/journal.pone.0071566

19.

Langenberg

JCM

Thomas

Donker

JMW

van Rijen

MML

Kluytmans

JAJW

van der Laan

. Evaluation of staphylococcus aureus eradication therapy in vascular surgery. PLoS One. 2016;11(8):e01610 58. doi:10.1371/journal.pone.0161058

20.

Roth

James

. Microbial Ecology of the Skin. Annu Rev Microbiol. 1988;42:441–464. doi:10.1146/annurev.mi.42.100188.002301

21.

Grice

Segre

. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–253. doi:10.1038/nrmicro2537

22.

Global Guidelines for the Prevention of Surgical Site Infection. Global Guidelines for the Prevention of Surgical Site Infection. World Health Organization; 2016. http://www.ncbi.nlm.nih.gov/pubmed/27929621. Accessed May 20, 2020.

23.

Wang

Jerosch-Herold

Jacobs

Shahar

Folsom

. Coronary risk factors and myocardial perfusion in asymptomatic adults: The Multi-Ethnic Study Of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;47(3):565–572. doi:10.1016/j.jacc.2005.09.036

24.

Ijzerman

Serne

van Weissenbruch

de Jongh

Stehouwer

CDA

. Cigarette smoking is associated with an acute impairment of microvascular function in humans. Clin Sci (Lond). 2003;104(3):247–252. doi:10.1042/CS20020318

25.

Kaufmann

Gnecchi-Ruscone

Schäfers

Lüscher

Camici

. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol. 2000;36(1):103–109. doi:S0735-1097(00)00697-5

26.

Levy

Schiffrin

Mourad

, et al. Impaired tissue perfusion a pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008;118(9):968–976. doi:10.1161/CIRCULATIONAHA.107.763730

27.

Gottrup

. Oxygen in Wound Healing and Infection. World J Surg. 2004;28(3):312–315. doi:10.1007/s00268-003-7398-5

28.

Bode

LGM

Rijen

MML van

Wertheim

, et al. Long-term mortality after rapid screening and decolonization of staphylococcus aureus carriers. Ann Surg. 2016;263(3):511–515. doi:10.1097/SLA.0000000000001060

29.

Vogel

Symons

Flum

. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47(2):264–269. doi:10.1016/j.jvs.2007.10.030

30.

Chiu

KWH

Davies

RSM

Nightingale

Bradbury

Adam

. Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg. 2010;39(4):460–471. doi:10.1016/j.ejvs.2009.12.014

31.

Kieffer

Sabatier

Plissonnier

Knosalla

. Prosthetic graft infection after descending thoracic/thoracoabdominal aortic aneurysmectomy: management with in situ arterial allografts. J Vasc Surg. 2001;33(4):671–678. doi:10.1067/mva.2001.112314

32.

Swain

Calligaro

Dougherty

. Management of infected aortic prosthetic grafts. Vasc Endovascular Surg. 2004;38(1):75–82. doi:10.1177/153857440403800110

33.

O’Connor

Andrew

Batt

Becquemin

. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44(1):38–45. doi:10.1016/j.jvs.2006.02.053

34.

Accessed May 29, 2020. https://english.ccmo.nl/investigators/legal-framework-for-medical-scientific-research/your-research-is-it-subject-to-the-wmo-or-not